We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mechanism Explains Selective Pruning of Neuronal Stem Cells

By Biotechdaily staff writers
Posted on 12 Aug 2003
Researchers have identified a mechanism that triggers the death of a portion of the stem cell population in the developing brain, thereby limiting the number of cells to an appropriate number and location for the brain to develop in a normal fashion.

Investigators from the Medical College of Georgia (Atlanta, USA) and the University of Georgia (Atlanta, USA) found that initiation of apoptosis depended on the presence of two triggering factors, elevated levels of the lipid ceramide and expression of the protein prostate apoptosis response 4 (PAR-4).

By employing specific antibodies, the investigators showed that potentially apoptotic cells stained for proliferating cell nuclear antigen (a nuclear mitosis marker protein), but not for nestin (a marker for maturing nerve cells). More...
In mitotic cells, asymmetric distribution of PAR-4 and nestin resulted in one nestin(-)/PAR-4(+) daughter cell, in which ceramide elevation induced apoptosis. The other cell was nestin(+), but PAR-4(-), and was not apoptotic. This asymmetric distribution of PAR-4 coupled with a simultaneous elevation of endogenous ceramide provided a possible mechanism underlying asymmetric differentiation and apoptosis of neuronal stem cells in the developing brain. These findings were published July 28, 2003, in the online edition of the Journal of Cell Biology.

"During normal development in the central nervous system there is a great deal of cell death that occurs that seems to be required to create the final shape and structure of the brain,” explained senior author Dr. Brian G. Condie, a developmental neurobiologist at the University of Georgia. "One of the ideas behind why there is an excess of cells generated during development is that it may be a mechanism for compensating for environmental stresses or other types of stresses that an embryo may encounter during development. So you actually generate an excess of the cells you need and then prune those cells back to an appropriate number and location for the brain to develop in a normal fashion.”





Related Links:
Medical College of Georgia
University of Georgia

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.